Abstract Background Pneumonia from SARS-CoV-2 is difficult to distinguish from other viral
and bacterial etiologies. Broad-spectrum antimicrobials are frequently prescribed to patients …

Background Evidence around prevalence of bacterial coinfection and pattern of antibiotic
use in COVID-19 is controversial although high prevalence rates of bacterial coinfection …

Background: The first wave of COVID-19 pandemic may have significantly impacted
antimicrobial consumption in hospitals. The objective of this study was to assess the …

Since the start of the COVID-19 pandemic, there has been concern about the concomitant
rise of antimicrobial resistance (AMR). While bacterial co-infections seem rare in COVID-19 …

Procalcitonin (PCT) is useful for differentiating between viral and bacterial infections and for
reducing the unnecessary use of antibiotics. As the rise of antimicrobial resistance reaches …

Abstract Coronavirus disease-19 (COVID-19) is an emerging infectious disease caused by
SARS-CoV-2 that has rapidly evolved into a pandemic to cause over 600 million infections …

Background: Literature suggests that antibiotic prescribing in COVID-19 patients is high.
Currently, there are insufficient data on what drives antibiotic prescribing practices …

Introduction Considering the ongoing increase in antibiotic resistance, the importance of
judicious use of antibiotics through reduction of exposure is crucial. Adding procalcitonin …

What is known and Objective Procalcitonin (PCT) levels rise in systemic inflammation,
especially if bacterial in origin. COVID‐19, caused by the novel coronavirus SARS‐CoV‐2 …

Background The first wave of COVID-19 pandemic may have significantly impacted
antimicrobial consumption in hospitals. The objective of this study was to assess the …